{
    "Orphapacket": {
        "ORPHApacketId": "686468",
        "creationDate": "2025-06-26 11:48:15",
        "version": "1.3.42 / 4.1.8 [2025-03-03]",
        "copyright": "Orphanet (c) 2025",
        "ORPHAcode": "686468",
        "Label": "Post 5-alpha-reductase inhibitors treatment syndrome",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_686468",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "A rare neurologic disease characterized by persistent side effects of terminated 5-alpha-reductase inhibitor treatment including impaired sexual function (low libido erectile dysfunction diminished semen volume and force) genital numbness or paresthesia gynecomastia depression brain fog and elevated anxiety. Additional symptoms may include muscular problems (tics muscle spasms tremors involuntary muscle contraction and muscular ache) joint pain chronic fatigue migraine decreased body temperature and dry skin."
        },
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "98006",
                        "Label": "Rare neurologic disease"
                    }
                ]
            }
        ],
        "TypeOfInheritances": {
            "TypeOfInheritance": [
                {
                    "value": "Not applicable"
                }
            ]
        }
    }
}